The Drug Enforcement Administration has contacted 25 “designated participants” to testify at a Dec. 2 hearing about marijuana ...

The Controlled Substances Act also requires clinicians obtain a separate DEA registration in each state where their patients are located. Congress expected the DEA to issue the special ...

the US Drug Enforcement Administration (DEA) announced plans to hold an administrative hearing on its proposal to move “marijuana” from Schedule I of the Controlled Substances Act — the most ...

The Drug Enforcement Administration announced in early 2024 that it would act on President Joe Biden's call to reclassify ...

Cannabis stocks will be in focus as DEA hearing on rescheduling marijuana is being delayed until 2025. Read more here.

And this spring, the Justice Department—including the Drug Enforcement Administration—acquiesced, marking the first loosening ...

(THE CONVERSATION/AP) - The Drug Enforcement Administration announced in early 2024 that it would act on President Joe Biden’s call to reclassify marijuana, moving it from the tightly controlled ...

An overview of federal and state laws and legal issues impacting physicians, non-physician practitioners (NPPs), and health ...

All recreational drug use ballot initiatives failed in the 2024 elections. Only one medical marijuana measure passed in ...

The settlement resolves the allegations Covetrus violated the Controlled Substances Act and other related regulations.

Village Farms International will represent the cannabis industry in the DEA hearing on marijuana rescheduling, the only ...

The Drug Enforcement Administration in 2006 warned drug distribution companies of a growing epidemic of prescription opioid ...